Recursos del Paciente
Manténgase sano!
19 Resultados de su búsqueda "Obesity".
Videos de salud - 19
Gen X and Baby Boomers Addicted to Ultra-Processed Foods, Study Finds
1 in 5 women and 1 in 10 men from Generation X and the tail end of the Baby Boom meet the criteria for addiction to ultra-processed foods, researchers say.
Could Ditching Daylight Saving Time Improve America’s Health?
Researchers compare three hotly debated time policies and find a surprising winner when it comes to improving health outcomes for millions of people.
Metabolic Syndrome Linked to Increased Risk of Parkinson’s Disease
In a new study, people with metabolic syndrome were 40% more likely to be diagnosed with Parkinson’s disease. Metabolic Syndrome is a cluster of conditions that increase the risk of heart disease, stroke and type 2 diabetes.
Does Losing Weight Before IVF Improve Chances For Pregnancy?
A new study finds women with obesity who lose weight before IVF have increased odds of getting pregnant, especially through natural conception.
Weight Returns Within Months Of Stopping Anti-Obesity Drugs, Study Finds
People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.
Obesity-Related Cancer Deaths Tripled Over the Past Two Decades, Study Finds
Researchers discover steep increases in cancer deaths linked to obesity since 1999, especially among women, older adults and Black people.
How Does BMI Affect Breast Cancer Risk in Postmenopausal Women?
A new study finds the combination of excess weight and heart disease in postmenopausal women is associated with an especially high risk of developing breast cancer.
GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers
A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.
Calorie Restriction May Lead to Small Improvements in Depression, Study Finds
A new study finds restricting calories or eating low-fat may slightly reduce depressive symptoms, but researchers say the evidence is limited.
Popular Weight Loss Drugs Do Not Increase the Risk of Depression, Anxiety or Suicidal Ideation, Study Finds
In a new study, researchers found no association between treatment with GLP-1 Receptor Agonists like Ozempic and Wegovy and increased risk of adverse psychiatric events.
Ultra-Processed Foods Linked to Premature, Preventable Deaths
A new study finds the more ultra-processed foods you eat, the higher your risk of dying prematurely from all causes.
Unhealthy Diet and Middle-Age Belly Fat Linked to Memory and Other Cognitive Problems
A new study finds diet quality and waist-to-hip ratio strongly impact brain function as you age.
Just Like Belly Fat, Muscle Fat May Increase the Risk of Serious Heart Disease
A new study finds people with pockets of fat inside their muscles are at increased risk of hospitalization of death from heart attack.
Is the Definition of Obesity About to Change?
An international group of medical experts says body mass index is not a reliable way to diagnose obesity. Members of the Commission on Clinical Obesity are recommending new methods that also consider location of excess body fat and objective symptoms of disease.
How Effective Are GLP-1 Meds for Weight Loss in People Without Diabetes?
A new study finds using GLP-1 receptor agonists to treat obesity in otherwise healthy adults is safe and very effective.
Rating the Best Diets for 2025
U.S. News & World Report, working with leading medical and nutrition experts, reveals a list of the best diets for overall health and specific conditions.
U.S. Obesity Rate Drops for the First Time in a Decade
New study examines U.S. trends in body mass index and obesity and finds improving numbers, driven in part by GLP-1 weight-loss drugs.
Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds
New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.
Semaglutide Helps Prevent Kidney Damage in People with Obesity
A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.